180 related articles for article (PubMed ID: 32877259)
1. Update on the Status and Impact of the National Eye Institute Audacious Goals Initiative for Regenerative Medicine.
Becker SM; Wright CB
J Ocul Pharmacol Ther; 2021 Apr; 37(3):144-146. PubMed ID: 32877259
[No Abstract] [Full Text] [Related]
2. Report on the National Eye Institute Audacious Goals Initiative: Regenerating the Optic Nerve.
Goldberg JL; Guido W;
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1271-5. PubMed ID: 26990163
[TBL] [Abstract][Full Text] [Related]
3. The NEI Audacious Goals Initiative: Advancing the Frontier of Regenerative Medicine.
Becker SM; Tumminia SJ; Chiang MF
Transl Vis Sci Technol; 2021 Aug; 10(10):2. PubMed ID: 34383880
[TBL] [Abstract][Full Text] [Related]
4. Special Commentary: Early Clinical Development of Cell Replacement Therapy: Considerations for the National Eye Institute Audacious Goals Initiative.
Levin LA; Miller JW; Zack DJ; Friedlander M; Smith LEH
Ophthalmology; 2017 Jul; 124(7):926-934. PubMed ID: 28365209
[TBL] [Abstract][Full Text] [Related]
5. Report on the National Eye Institute Audacious Goals Initiative: Photoreceptor Regeneration and Integration Workshop.
Gamm DM; Wong R;
Transl Vis Sci Technol; 2015 Nov; 4(6):2. PubMed ID: 26629398
[TBL] [Abstract][Full Text] [Related]
6. Report on the National Eye Institute's Audacious Goals Initiative: Creating a Cellular Environment for Neuroregeneration.
Burns ME; Stevens B
eNeuro; 2018; 5(2):. PubMed ID: 29766041
[TBL] [Abstract][Full Text] [Related]
7. Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources.
Vetter ML; Hitchcock PF;
Transl Vis Sci Technol; 2017 Mar; 6(2):5. PubMed ID: 28316878
[TBL] [Abstract][Full Text] [Related]
8. Developing cellular therapies for retinal degenerative diseases.
Bharti K; Rao M; Hull SC; Stroncek D; Brooks BP; Feigal E; van Meurs JC; Huang CA; Miller SS
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1191-202. PubMed ID: 24573369
[TBL] [Abstract][Full Text] [Related]
9. NEI audacious goals initiative to catalyze innovation.
Sieving PA
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7149-50. PubMed ID: 23047720
[No Abstract] [Full Text] [Related]
10. NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future.
Wright C; Mazzucco AE; Becker SM; Sieving PA; Tumminia SJ
Transl Vis Sci Technol; 2020 Jun; 9(7):49. PubMed ID: 32832254
[TBL] [Abstract][Full Text] [Related]
11. Translating Dental, Oral, and Craniofacial Regenerative Medicine Innovations to the Clinic through Interdisciplinary Commercial Translation Architecture.
Taylor DP; Yoshida M; Fuller K; Giannobile WV; Sfeir CS; Wagner WR; Kohn DH
J Dent Res; 2021 Sep; 100(10):1039-1046. PubMed ID: 33906502
[TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence at the national eye institute.
Sherif NA; Chew EY; Chiang MF; Hribar M; Gao J; Goetz KE
Curr Opin Ophthalmol; 2022 Nov; 33(6):579-584. PubMed ID: 36206110
[TBL] [Abstract][Full Text] [Related]
13. Regen Med California Institute for Regenerative Medicine Profile CIRM 2.0.
McCormack K
Regen Med; 2016 Dec; 11(8):759-762. PubMed ID: 27908225
[TBL] [Abstract][Full Text] [Related]
14. [Research in retinal regenerative medicine].
Takahashi M
Nihon Rinsho; 2008 May; 66(5):915-9. PubMed ID: 18464510
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the Activity of Stem and Progenitor Cells by Immune Cells.
Alshoubaki YK; Nayer B; Das S; Martino MM
Stem Cells Transl Med; 2022 Mar; 11(3):248-258. PubMed ID: 35303109
[TBL] [Abstract][Full Text] [Related]
16. Reconnecting Eye to Brain.
Crair MC; Mason CA
J Neurosci; 2016 Oct; 36(42):10707-10722. PubMed ID: 27798125
[TBL] [Abstract][Full Text] [Related]
17. NEI's audacious goals initiative.
Salowe RJ; O'Brien JM
Ophthalmology; 2014 Mar; 121(3):615-6. PubMed ID: 24581751
[No Abstract] [Full Text] [Related]
18. CIRM tools and technologies: Breaking bottlenecks to the development of stem cell therapies.
Collins LR; Shepard KA
Stem Cells Transl Med; 2020 Oct; 9(10):1129-1136. PubMed ID: 32619326
[TBL] [Abstract][Full Text] [Related]
19. The Turkish version of the National Eye Institute Refractive Error Quality of Life Instrument: translation, validity and reliability.
Toker E; Onal S; Eraslan M; Eyriparmak M
Qual Life Res; 2008 Dec; 17(10):1269-76. PubMed ID: 18979231
[TBL] [Abstract][Full Text] [Related]
20. Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies.
Ratcliffe E; Glen KE; Naing MW; Williams DJ
Br Med Bull; 2013; 108():73-94. PubMed ID: 24200742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
